Neuphoria Therapeutics (NEUP) Shares Outstanding (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted Shares Outstanding of 124.66 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from 124.66 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Shares Outstanding (2020 - 2026) Analysis & Trends
Since fiscal Q4 2020, Neuphoria Therapeutics has reported Shares Outstanding for 16 quarters.
- Annual Shares Outstanding shows a five-year compound annual growth rate of 13.9% (FY2021 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Shares Outstanding was 124.66 million in FY2025 (unchanged), 124.66 million in FY2024 (+1.9%), 122.39 million in FY2023 (+8.5%) and 112.77 million in FY2022 (+73.5%).
- The year-over-year growth in Shares Outstanding has ranged between 0.0% (fiscal Q1 2025) and 73.5% (fiscal Q4 2022) over the last five years.
- According to Business Quant data, Shares Outstanding for the three prior fiscal quarters was 124.66 million (Q3 2026), 124.66 million (Q2 2026) and 124.66 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 124.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.66 Mn |
| Mar 31, 2026 | 124.66 Mn |
| Dec 31, 2025 | 124.66 Mn |
| Sep 30, 2025 | 124.66 Mn |
| Jun 30, 2025 | 124.66 Mn |
| Mar 31, 2025 | 124.66 Mn |
| Dec 31, 2024 | 124.66 Mn |
| Sep 30, 2024 | 124.66 Mn |
| Jun 30, 2024 | 124.66 Mn |
| Mar 31, 2024 | 124.66 Mn |
| Dec 31, 2023 | 124.66 Mn |
| Sep 30, 2023 | 124.66 Mn |
| Jun 30, 2023 | 122.39 Mn |
| Jun 30, 2022 | 112.77 Mn |
| Jun 30, 2021 | 64.99 Mn |
| Jun 30, 2020 | 45.40 Mn |
API Access
Neuphoria Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();